Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010152 · ClinicalTrials.gov registry record · Phase 1
Comparative Bioavailability Study of Codeine Sulfate
A Phase 1 study, sponsored by Roxane Laboratories.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT01010152 is a Phase 1 study that has completed, run by Roxane Laboratories. The registered enrollment target is 34 participants.
The verdict
NCT01010152, a Phase 1 study, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
The objective of this study was to assess the comparative bioavailability of codeine from Roxane Laboratories' Codeine Sulfate 30mg tablets to Tylenol® #3 (acetaminophen 300mg with codeine phosphate 30mg) under fasted conditions
Interventions
- DRUG Codeine Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01010152
The ClinicalTrials.gov registry entry for NCT01010152 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roxane Laboratories, which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Codeine Sulfate is the first listed.
NCT01010152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01010152 about?
NCT01010152 is a clinical study titled "Comparative Bioavailability Study of Codeine Sulfate". The objective of this study was to assess the comparative bioavailability of codeine from Roxane Laboratories' Codeine Sulfate 30mg tablets to Tylenol® #3 (acetaminophen 300mg with codeine phosphate 30mg) under fasted conditions
What is the current status of trial NCT01010152?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2008-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT01010152?
The interventions under investigation include: Codeine Sulfate (DRUG).
Who is sponsoring clinical trial NCT01010152?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.